Compounded medications are not FDA approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.

Provider profile

TelyRx — compounded GLP-1 pricing & profile

Released: · Last reviewed:

Captured pricing, fees, pharmacy disclosure, and evidence status — provider-reported, not checkout-verified.

TelyRx is a compounded GLP-1 access channel captured in this site's provider directory. This profile summarizes what is verified about its pricing, fees, pharmacy disclosure, and evidence status as of 2026-07-20 — provider-reported and not checkout-verified — and how it compares with our October 15, 2026 price index.

Provider-reported, not checkout-verified. This profile is built from captured public data and is not a scored, full editorial review. TelyRx is not assigned a score or a "verified cheapest" claim; figures are provided for transparency and comparison and should be confirmed with the provider.

Captured pricing

TelyRx does not publish a single flat compounded price in the captured data. Semaglutide: No current compounded semaglutide price used. Tirzepatide: No current compounded tirzepatide price used. Because no stable per-plan figure was captured, TelyRx is shown for transparency but is not placed in the ranked pricing tables. Confirm current pricing on the provider's own page before relying on any figure.

How TelyRx compares

All-in monthly cost folds every required charge into one number. This is where TelyRx sits against our October 15, 2026 price index, built from prices read on each provider's own page:

TelyRx vs the October 15, 2026 compounded GLP-1 price index (lowest all-in monthly figure per program, standard-dose injections)
MedicationTelyRxIndex rangeNexLife (#1 overall)
compounded semaglutidenot in the index$49–$193.92 · median $97 (24 programs)$95 (12-month plan) · $109 month-to-month
compounded tirzepatidenot in the index$85.58–$449 · median $149 (31 programs)$115 (12-month plan) · $129 month-to-month

The index range includes sale prices, prepaid terms and "from" figures; the tirzepatide and semaglutide tables show each program's conditions. NexLife is our #1 overall pick under the v4.1 rubric, not the lowest price in the index.

Fees, pharmacy, and disclosure

TelyRx — captured structure and disclosures (2026-07-20)
CategoryCompounded-GLP-1-focused
Current statusBrand-only access pharmacy — not a compounded-provider ranking candidate
Membership / program feeMedication price; telehealth/prescription pathway may add requirements
Pharmacy disclosureNot verified
Material relationshipNo known material relationship — publisher attested 2026-07-20; independent verification not performed
Evidence statusPENDING · confidence moderate
Last checked2026-07-20
Official sourceprovider page

Capture note: Refill quantity and dose must be confirmed; not directly comparable to monthly telehealth bundles.

How to evaluate TelyRx before paying

Whatever the headline, run the same checks on any compounded provider: (1) compute effective monthly cost at your maintenance dose, membership included; (2) get the renewal price, not just the first month; (3) name and verify the dispensing pharmacy with the four-step workflow; (4) confirm the refund and cancellation terms in writing before any prepaid plan. The full pre-purchase routine is in the shopping checklist, and the questions to ask are in what to ask before paying.

Frequently asked questions

How much does TelyRx charge for compounded GLP-1?

TelyRx did not publish a single flat compounded price in the captured data — no current compounded semaglutide price used. Confirm current pricing directly with the provider, and compute effective monthly cost at your maintenance dose before comparing.

Does TelyRx charge a membership fee?

A membership or program fee was not clearly reported. Captured: Medication price; telehealth/prescription pathway may add requirements. A required membership belongs in the effective-cost math, so add it in before comparing TelyRx to any flat-priced provider.

Is TelyRx's pricing verified?

No. TelyRx's evidence status is verification pending (confidence moderate); figures are provider-reported or independently calculated, not checkout-verified, and its pharmacy disclosure is "not verified". Treat every figure as a starting point to confirm, not a guarantee.